At the end of this presentation, the participant will be able to:

• Analyze potential benefits of ultra-hypofractionation in prostate cancer.
• Determine the synergy between BT an EBRT in the ultra-hypofractionation setting.
• Analyze the importance of BT in ultra-hypofractionation.
• Discuss access worflow of pt treated